INTESTINE Vol.21 No.3(2)


特集名 直腸早期癌─治療の新たな展開
題名 直腸T1癌の特徴─結腸T1癌と比較して
発刊年月 2017年 05月
著者 本部 卓也 国立がん研究センター東病院消化管内視鏡科
著者 依田 雄介 国立がん研究センター東病院消化管内視鏡科
著者 池松 弘朗 国立がん研究センター東病院消化管内視鏡科
【 要旨 】 「大腸癌治療ガイドライン」に沿って治療された大腸pT1癌の長期予後は良好であった.しかし,ガイドラインに反して内視鏡治療後にリンパ節転移高リスク群を経過観察した場合,直腸pT1癌(とくに下部直腸癌)において局所再発が多く認められたことから,高リスク直腸pT1癌に対しては,外科手術を標準とする追加治療が必要と考える.加えて,手術により肛門機能を損なう可能性のある下部直腸pT1癌に対しては,機能温存可能な新たな追加治療の開発が重要と考える.
Theme New evolvement in treatment for early rectal cancer
Title Characteristics of T1 rectal cancer -- in comparison with T1 colon cancer
Author Takuya Hombu Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East
Author Yusuke Yoda Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East
Author Hiroaki Ikematsu Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East
[ Summary ] In the patients with submucosal (T1) colorectal cancer treated in accordance with the Japanese guideline, long-term outcomes were good. Recently, expansion of the indication for endoscopic treatment of T1 cancer have been discussed. However, the risk of local recurrence was significantly higher in the patients with high-risk T1 rectal cancer than in those with T1 colon cancer treated with only endoscopic resection. Currently, the addition of surgery is recommended for patients with high-risk T1 rectal cancer that indicates a high risk of tumor progression. However, rectal surgery is more invasive than colonic surgery. Thus, a few patients refused surgery in view of quality of life. Development of a new treatment will be an urgent need in the future to reduce the recurrence rate while preserving the anatomy and function of the anus.
戻る